Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...

Lumicera Health Services announced today it has secured a purchase agreement with Anda, Inc., an independent wholly owned subsidiary of Teva Pharmaceutical Industries Ltd., for a lower-priced ...

Celltrion launches Steqeyma autoimmune treatment in U.S. market Celltrion unveils its competitive approach for Steqeyma in ...

Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 ...

The new bill would also require state Medicaid programs to report National Average Drug Acquisition Costs (NADAC) as a way to ...

Johnson & Johnson’s inflammatory disease drug Stelara has been approved in Europe for ulcerative colitis (UC), a new use for the multibillion dollar blockbuster. The European Commission cleared ...

Prescription medication costs are forcing some hard choices for many Nevadans. Two years ago, a proposal that offered hope sailed through the Democrat-majority Nevada Legislature only to be vetoed ...

AMD unveiled the first of its 9000-series graphics cards, the Radeon RX 9070 and RX 9070 XT, on Friday, 28 February 2024. The cards have now gone on sale through South African retailers ...

Bimekizumab – an IL-17A and IL-17F inhibitor – outdid both placebo and IL-12/IL-23 blocker Stelara (ustekinumab) when it came to clearing the skin of patients with moderate-to-severe chronic ...

Pharmacy benefit managers take considerably different approaches to managing patient access to biosimilars, or cheaper versions of biologics such as Humira and Stelara. Trump's executive orders on ...